Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
CLU VHH recombinant monoclonal antibody
CNR1 VHH recombinant monoclonal antibody
CSF1 VHH recombinant monoclonal antibody
CSF1R VHH recombinant monoclonal antibody
CSF2 VHH recombinant monoclonal antibody
CSF2RA VHH recombinant monoclonal antibody
CSF2RB VHH recombinant monoclonal antibody
CSF3R VHH recombinant monoclonal antibody
CTGF VHH recombinant monoclonal antibody
CTLA4 VHH recombinant monoclonal antibody
CX3CL1 VHH recombinant monoclonal antibody
CXCL10 VHH recombinant monoclonal antibody